These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 17984184)

  • 1. Have we forgotten the purpose of phase III studies?
    Flynn JM; Byrd JC
    J Clin Oncol; 2007 Dec; 25(35):5553-5. PubMed ID: 17984184
    [No Abstract]   [Full Text] [Related]  

  • 2. Advances in the use of alemtuzumab in CLL.
    Stilgenbauer S
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):23-4. PubMed ID: 18322437
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current concepts in chronic lymphocytic leukemia. Better chances for young patients].
    Hallek M; Bergmann M; Goede V; Fingerle-Rowson G; Schweighofer C; Schmitt B; Wendtner CM; Emmerich B
    MMW Fortschr Med; 2003 Jul; 145(27-28):46-9. PubMed ID: 14587189
    [No Abstract]   [Full Text] [Related]  

  • 4. Hillmen trial of alemtuzumab in first-line chronic lymphocytic leukemia still provides valuable information.
    Sirard C; Trehu EG
    J Clin Oncol; 2008 May; 26(14):2411-2; author reply 2412-3. PubMed ID: 18467736
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody).
    Karlsson C; Hansson L; Celsing F; Lundin J
    Leukemia; 2007 Mar; 21(3):511-4. PubMed ID: 17215854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy of chronic lymphocytic leukemia with purine analogs and monoclonal antibodies.
    Robak T
    Transfus Apher Sci; 2005 Feb; 32(1):33-44. PubMed ID: 15737872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charting the path to the cure of chronic lymphocytic leukemia: consolidation strategies currently lead the way.
    Tam CS
    Leuk Lymphoma; 2009 Oct; 50(10):1557-8. PubMed ID: 19757304
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment options for newly diagnosed patients with chronic lymphocytic leukemia.
    Erba HP
    Curr Hematol Rep; 2004 Jan; 3(1):47-53. PubMed ID: 14695850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic lymphocytic leukaemia. Current strategy and new perspectives of treatment.
    Rai KR
    Haematologica; 1999 Jun; 84 Suppl EHA-4():94-5. PubMed ID: 10907481
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimal First-Line Therapy for Previously Untreated Chronic Lymphocytic Leukemia: The Case for Chemotherapy.
    Brown JR
    Oncology (Williston Park); 2015 Jun; 29(6):442, 444. PubMed ID: 26091679
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics of alemtuzumab in combination with fludarabine in patients with relapsed or refractory B-cell chronic lymphocytic leukemia.
    Elter T; Kilp J; Borchmann P; Schulz H; Hallek M; Engert A
    Haematologica; 2009 Jan; 94(1):150-2. PubMed ID: 19001286
    [No Abstract]   [Full Text] [Related]  

  • 12. Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands.
    Laros-van Gorkom BA; Huisman CA; Wijermans PW; Schipperus MR
    Neth J Med; 2007 Oct; 65(9):333-8. PubMed ID: 17954952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What choices are available for treatment of the patient with chronic lymphocytic leukemia who is fludarabine-refractory?
    Byrd JC; Rai KR
    Semin Oncol; 2000 Aug; 27(4):xii-xv; discussion xv-xvi. PubMed ID: 10950363
    [No Abstract]   [Full Text] [Related]  

  • 14. Alemtuzumab in the treatment of chronic lymphocytic lymphoma.
    Boyd K; Dearden CE
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):525-33. PubMed ID: 18402519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A personal history of the CAMPATH-1H antibody.
    Waldmann H
    Med Oncol; 2002; 19 Suppl():S3-9. PubMed ID: 12180490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alemtuzumab: new indication. First line treatment of chronic lymphocytic leukaemia: continue to use oral chlorambucil.
    Prescrire Int; 2009 Apr; 18(100):60. PubMed ID: 19585719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conceptual aspects of combining rituximab and Campath-1H in the treatment of chronic lymphocytic leukemia.
    Nabhan C; Rosen ST
    Semin Oncol; 2002 Feb; 29(1 Suppl 2):75-80. PubMed ID: 11842392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A network meta-analysis of progression free survival and overall survival in first-line treatment of chronic lymphocytic leukemia.
    Ladyzynski P; Molik M; Foltynski P
    Cancer Treat Rev; 2015 Feb; 41(2):77-93. PubMed ID: 25512118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variations on the fludarabine, cyclophosphamide, and rituximab combination in chronic lymphocytic leukemia therapy: what have we learned?
    Ahmadi T; Schuster SJ
    J Clin Oncol; 2009 Feb; 27(4):479-80. PubMed ID: 19075263
    [No Abstract]   [Full Text] [Related]  

  • 20. Chronic lymphocytic leukaemia resistant to both fludarabine and alemtuzumab--double jeopardy.
    Mulligan SP
    Leuk Lymphoma; 2007 Oct; 48(10):1885-7. PubMed ID: 17917953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.